1140
J.T. Kim et al. / Polyhedron 19 (2000) 1139–1143
(NaSPh) was prepared from the reaction of sodium and thio-
phenol in diethyl ether.
solution was stood at ambient temperature. Finally, a dark
red powder of [Ti3O(SPh)3Cl4(CH3CN)5]PCH3CNP
(C2H5)2O was obtained in 74% yield.
2.1. [Et4N]2[Ti(SPh)6] (I)
Calc. for Ti3S3O2N6Cl4C34H43: C, 43.03; H, 4.53; N, 8.85;
S, 10.14. Found: C, 43.24; H, 4.24; N, 8.76; S, 12.01%. FT-
IR (cmy1): n(Ti–O), 600.5; n(CH3CN), 2310.3, 2280;
A 250-ml Schlenk flask was charged with 2.26 g (17.23
mmol) of NaSPh, 1.10 g (5.30 mmol) of Et4NBr and a
stirring bar. To this mixture was added 50 ml of CH3CN via
a cannula with stirring at ambient temperature and 0.29 ml
(2.65 mmol) of TiCl4 was injected using a syringe. The color
of the solution turned to dark red immediately. After 2 h, the
solution was filtered through a fine porosity fritted funnel; to
the dark red filtrate, 50 ml of diethyl ether was added and the
resulting solution was left to stand at ambient temperature.
Finally, dark red crystalline materials were obtained in 80%
yield. Calc. for TiS6N2C52H70: C, 64.83; H, 7.27; N, 2.92; S,
19.97. Found: C, 64.91; H, 7.34; N, 3.01; S, 21.52%. FT-IR
1
n(Ti–SPh), 481, 429. H NMR in DMF-d7: d (CH3 in
CH3CN ligand and free CH3CN); 1.92–1.97 (m, 18H), d
(CH2 in Et2O); 3.28 (q, 4H), d (CH3 in Et2O); 1.06 (t, 6H),
d (C6H5 in SPh ligand); 7.252–7.285 (m, 15H).
2.3. X-ray crystallography
Single X-ray diffraction data forboth crystalsarepresented
in Table 1. Diffraction data were collected at ambient tem-
perature on a Bruker P4 four circle diffractometer using
Mo Ka radiation. Intensity data were collected by using a u–
2u step scan technique and for all data sets the condition of
the crystal was monitored by measuring 2 standard reflec-
tions. The solutions of both structures were carried out by a
combination of heavy atom Patterson techniques, direct
methods and Fourier techniques. The refinement of the struc-
tures by full-matrix least-squares methods was based on 2640
unique reflections (2us458, I)2s) for compound I, and
4361 unique reflections (2us22.58, I)2s) for compound
II. Anisotropic temperature factors were used for all non-
hydrogen atoms in compounds I and II, except solvent mol-
ecules packed in the lattice for compound II. At the current
stage of refinement on 312 parameters for compound I and
459 parameters for compound II with all atoms present in the
asymmetric units, Rs0.0383, Rws0.0989 for compound I
and Rs0.0715, Rws0.1982 for compound II.
(cmy1): n(Ti–SPh); 480, 430. H NMR in acetonitrile-d3:
1
d (CH3 in Et4Nq); 1.18 (t, 24H), d (CH2 in Et4Nq); 3.21
(q, 16H), d (C6H5 in SPh ligand); 6.97–7.42 (m, 30H). The
Ph4Pq salt was also obtained by a similar syntheticprocedure
in 80% yield. Calc. for TiS6P2C84H70: C, 73.05; H, 5.07.
Found: C, 73.23; H, 5.12%. IR (KBr disc) (cmy1): n(Ti–
SPh), 480 and 420.
2.2. [Ti3O(SPh)3Cl4(CH3CN)5]PCH3CNP(C2H5)2O (II)
2.2.1. Method A
A 250-ml Schlenk flask was charged with 1.39 g (10.60
mmol) of NaSPh and a stirring bar. To this flask 30 ml of
CH3CN was added via a cannula with stirring at ambient
temperature, and 0.29 ml (2.65 mmol) of TiCl4 was injected
using a syringe. The color of the solution turned to dark red.
After 2 h, the solution was filtered through a fine porosity
fritted funnel. To the red filtrate 100 ml of diethyl ether was
added and the resulting solution was stood at ambient tem-
perature. Dark purple crystals and dark red crystals were
isolated and dried under vacuum. Finally, a 1:1 mixture of
dark purple crystals of TiCl3(CH3CN)3 and dark red crystals
of [Ti3O(SPh)3Cl4(CH3CN)5]PCH3CNP(C2H5)2O were
obtained (see below). The total yield was approximately
70% (based on Ti). 1H NMR in DMF-d7: d (CH2 in CH3CN
in ligand and free CH3CN); 1.95 (br, 27H), d (CH3 in Et2O);
3.382 (q, 4H), d (CH3 in Et2O); 1.068 (t, 6H), d (C6H5 in
SPh ligand); 7.126–7.277 (m, 15H).
Table 1
Crystallographic data for [Et4N]2[Ti(SPh)6] (I) and [Ti3O(SPh)3Cl4-
(CH3CN)5]PCH3CNP(C2H5)2O (II)
I
II
Formula
FW
TiS6N2C52H70
963.36
Ti3S3O2N6Cl4C34H43
948.96
Crystal system
Space group
triclinic
P1 (no. 2)
monoclinic
P21/c (no. 14)
13.139(1)
8.653(1)
38.544(3)
¯
˚
a (A)
11.113(2)
11.414(2)
13.075(2)
112.89(1)
92.29(1)
118.77(1)
2
1285.2(4)
20
0.71073
1.245
˚
b (A)
˚
c (A)
a (8)
b (8)
g (8)
90.94(1)
2.2.2. Method B
Z
4
TiCl4, 0.18 ml (1.68 mmol), was injected using a syringe
into a 250-ml Schlenk flask containing 20 ml of CH3CN. To
this solution 0.01 ml (0.56 mmol) of H2O diluted in 10 ml
of CH3CN was added and the solution was stirred at ambient
temperature for 10 min. The solution was transferred via a
cannula to a 250-ml schlenk flask charged with 0.88 g (6.72
mmol) of NaSPh and 20 ml of CH3CN. After 2 h, the solution
was filtered through a fine porosity fritted funnel; then to the
red filtrate 100 ml of diethyl ether was added and the resulting
3
˚
V (A )
4381.5(7)
20
0.71073
1.439
9.58
T (8C)
3
˚
l (A )
rcalc (g cmy3
)
m (cmy1
R a
)
4.46
0.0383
0.0989
0.0715
0.1982
Rw b
a RsSNNFoNyNFcNN/SNFoN.
b Rws[Sw(NFoNyNFcN)2/Sw(NFoN )]1/2, where ws1/s2(NFoN).
2
Wednesday May 24 01:45 PM
StyleTag -- Journal: POLY (Polyhedron) Article: 3445